The consortium consists of 22 partners that will work together to develop high quality chemical tools
Open science drug discovery partnership, READDI, aims to invest $125 million to prevent future pandemics
SGC and collaborators to create open research tools for Alzheimer’s disease research funded by National Institute on Aging
A collaboration between MSD and the SGC has resulted in the discovery of MRK-740, a potent inhibitor of PRDM9
A collection of well-characterized chemical probes and related reagents for the study of methylation-mediated signaling.